feed,title,long_url,short_url
Benzinga,"FDA Pushes Review Period For Bluebird bio's Neurodegenerative Disease, Thalassemia Gene Therapies",https://benzinga.com/general/biotech/22/01/25086799/fda-pushes-review-period-for-bluebird-bios-neurodegenerative-disease-thalassemia-gene-therapies,https://j.mp/3GHgTIP
